Data Presented at ASCO Show 26% Partial Response, 63% Clinical Benefit Incidence

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3722071 for the full story.

SUGAR LAND--June 4, 2008 Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- In addition to developing drugs for the marketplace the old fashioned way, with benefit of labs and scientists, pharma-biotech companies are increasingly turning to cash to pay for mergers and acquisitions that will hopefully fill their pipelines.

Companies featured: AstraZeneca (NYSE:AZN), Schering-Plough (NYSE:SGP), Mylan Laboratories (NYSE:MYL), Merck & Company (NYSE:MRK), Emergent BioSolutions Inc. (NYSE:EBS), Bristol-Myers Squibb Company (NYSE:BMY), Kosan Biosciences Inc. (NASDAQ:KOSN)

Kosan Biosciences Inc. (KOSN)

Q1 2008 Earnings Call

Complete Story »

Here are Thursdays biggest percentage gainers and losers in midday trading, along with top volume leaders, among companies with a market cap between $50 million and $750 million:Biggest percentage gainers:? Kosan Biosciences Inc. ( Nasdaq:KOSN), up 229.7% to $5.44 after announcing Bristol-Myers Squibb is buying the cancer therapeutics firm for $5.50 per share in cash.? Ultralife Batteries, Inc. ( Nasdaq:ULBI), up 24.2% to $12.01 after reporting second-quarter guidance above Wall Street??s expectations.? Elizabeth Arden, Inc. ( Nasdaq:RDEN), up 15.1% to $15.40 after it said it has contracted a long-term global licensing agreement with Liz Claiborne Inc. ( NYSE:LIZ) to manufacture and distribute Liz Claiborne fragrance brands.Biggest percentage losers:? KMG Chemicals, Inc. ( Nasdaq:KMGB), down 15.9% to $10.50 after reporting weak third-quarter results.? Community Valley Bancorp ( Nasdaq:CVLL), down 13% to $8.71 despite no reports from the firm.? Community Bankers Acquisition Corp. ( AMEX:BTC), down 12.6% to $6.40 despite an announcement that certain new investors bought about 4.1 million shares of common stock.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3697635 for the full story.

WITH RESPECT TO THE US’ GDP GROWTH, THE NATIONAL BUREAU OF ECONOMIC RESEARCH SEES A SIGNIFICANT DECLINE IN ECONOMIC ACTITIVY SPREAD ACROSS THE ECONOMY, WHICH WILL LAST MORE THAN A FEW MONTHS - WSJ - According to Robert Hall, economist at Stanford University, US economic data that has been reported provide (...) [More...]

A 6-Page Stock Profile for YMI is Now Available to View or Download as a PDF at www.geocities.com/mikehavrx/YMI.pdf While the market is focused on just the pending colorectal cancer trial data; it ignores several major points on YM BioSciences:(1) the ...

SGX Pharma ( Nasdaq: SGXP) 6-Month Chart Shares of SGX Pharma (SGXP) soared after hours Tuesday on news of an all-cash $64 million buyout from Eli Lilly (LLY). The buyout represented a premium of more than 100% at $3 per share for SGX, which is being ac...

Shares of Kosan Biosciences Inc. ( NASDAQ: KOSN), a biotechnology company and drug developer that focuses on the genetic manipulation of polyketides, which are used in antibiotics and anticancer drugs, more than tripled recently on the announcement of the signing of a definitive merger agreement with Bristol-Myers Squibb. Under the terms of the agreement, Bristol-Myers Squibb [...]

UP
Kosan Biosciences Inc (KOSN)
Joy Global Inc (JOYG)
Genvec Inc (GNVC)
GENESCO Inc (GCO)
Big Lots Inc (BIG)
DOWN
Tata Mtrs Ltd (TTM)
Navios Maritime Holdings Inc (NM)
Alfacell Corporation (ACEL)
Sunpower Corp (SPWR)
Verizon Communications (VZ)